We are live on ! Find out more
MAM

Monaco Asset Management Portfolio holdings

AUM $542M
1-Year Est. Return 54.4%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+54.4%
3 Year Est. Return
+96.99%
5 Year Est. Return
10 Year Est. Return
AUM
$334M
AUM Growth
-$5.65M
Cap. Flow
-$30.5M
Cap. Flow %
-9.12%
Top 10 Hldgs %
62.07%
Holding
89
New
11
Increased
12
Reduced
29
Closed
33

Top Buys

Rank Stock Value
1
GDX icon
VanEck Gold Miners ETF
GDX
+$16.3M
2
VTRS icon
Viatris
VTRS
+$5.29M
3
ZM icon
Zoom
ZM
+$5.07M
4
BIDU icon
Baidu
BIDU
+$3.01M
5
PARA
Paramount Global Class B
PARA
+$1.64M

Top Sells

Rank Stock Value
1
FATE icon
Fate Therapeutics
FATE
+$11.6M
2
AEM icon
Agnico Eagle Mines
AEM
+$8.05M
3
PFE icon
Pfizer
PFE
+$5.76M
4
PYPL icon
PayPal
PYPL
+$4.54M
5
B
Barrick Mining
B
+$4.48M

Sector Composition

Rank Sector Weight
1 Healthcare 22.24%
2 Materials 18.8%
3 Technology 6.47%
4 Communication Services 3.47%
5 Consumer Discretionary 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEON icon
51
VEON
VEON
$3.62B
$620K 0.19%
25,830
+2,030
+9% +$45.2K
PTON icon
52
Peloton Interactive
PTON
$2.77B
$600K 0.18%
140,000
-10,000
-7% -$49.4K
LKFT
53
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
$539K 0.16%
16,744
+10,000
+148% +$372K
DEC
54
Diversified Energy Company
DEC
$930M
$433K 0.13%
+36,000
New +$451K
TPIC
55
DELISTED
TPI Composites
TPIC
$146K 0.04%
+50,000
New +$147K
FLG
56
Flagstar Bank National Association
FLG
$5.93B
$41K 0.01%
+4,247
New +$78.5K
ACRS icon
57
Aclaris Therapeutics
ACRS
$726M
-979,399
Closed -$1.03M
ADVM
58
DELISTED
Adverum Biotechnologies
ADVM
-7,923
Closed -$59.6K
AG icon
59
First Majestic Silver
AG
$7.41B
-50,000
Closed -$308K
AU icon
60
AngloGold Ashanti
AU
$40.1B
-211,549
Closed -$3.95M
BLUE
61
DELISTED
bluebird bio
BLUE
-7,500
Closed -$207K
BZFD icon
62
BuzzFeed
BZFD
$99M
-125,000
Closed -$125K
C icon
63
Citigroup
C
$222B
-20,000
Closed -$1.03M
CMP icon
64
Compass Minerals
CMP
$1.23B
-20,000
Closed -$506K
DG icon
65
Dollar General
DG
$28B
-12,500
Closed -$1.7M
DNOW icon
66
DNOW Inc
DNOW
$2.58B
-128,771
Closed -$1.46M
ERIC icon
67
Ericsson
ERIC
$32.2B
-75,000
Closed -$473K
ESPR
68
DELISTED
Esperion Therapeutics
ESPR
-243,642
Closed -$728K
FMC icon
69
FMC
FMC
$1.34B
-45,000
Closed -$2.84M
B
70
Barrick Mining
B
$61.5B
-247,500
Closed -$4.48M
HTZ icon
71
Hertz
HTZ
$499M
-110,000
Closed -$1.14M
JSPR icon
72
Jasper Therapeutics
JSPR
$21M
-24,956
Closed -$197K
KOD icon
73
Kodiak Sciences
KOD
$2.6B
-380,610
Closed -$1.16M
MMM icon
74
3M
MMM
$90.9B
-35,880
Closed -$3.28M
MP icon
75
MP Materials
MP
$7.36B
-25,000
Closed -$496K

Similar funds

Monaco Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Monaco Asset Management held 89 positions worth $334M, down 1.7% from $340M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Monaco Asset Management withdrew a net $30.5M in Q1 2024, closing 33 positions and reducing 29 holdings. Its most notable exit was Pfizer, an estimated $5.76M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Materials and Technology.

Against the trend, Monaco Asset Management opened a new position in VanEck Gold Miners ETF worth $18.2M.

  • Monaco Asset Management's largest Q1 2024 buy was VanEck Gold Miners ETF: 574,500 shares worth $18.2M.
  • Monaco Asset Management added most to Viatris in Q1 2024, an estimated $5.29M increase.
  • Monaco Asset Management's biggest Q1 2024 reduction was Fate Therapeutics, cutting an estimated $11.6M.
  • Monaco Asset Management fully exited Pfizer in Q1 2024, selling an estimated $5.76M.
  • Monaco Asset Management's ten largest holdings make up 62% of its $334M portfolio in Q1 2024.
  • Monaco Asset Management opened 11 new positions and closed 33 in Q1 2024.
  • Monaco Asset Management's portfolio value fell 1.7% quarter-over-quarter to $334M.

Based on Monaco Asset Management's 13F filing for Q1 2024, filed 9 May 2024.